BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37611839)

  • 1. Evodiamine impairs HIF1A histone lactylation to inhibit Sema3A-mediated angiogenesis and PD-L1 by inducing ferroptosis in prostate cancer.
    Yu Y; Huang X; Liang C; Zhang P
    Eur J Pharmacol; 2023 Oct; 957():176007. PubMed ID: 37611839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF1α lactylation enhances KIAA1199 transcription to promote angiogenesis and vasculogenic mimicry in prostate cancer.
    Luo Y; Yang Z; Yu Y; Zhang P
    Int J Biol Macromol; 2022 Dec; 222(Pt B):2225-2243. PubMed ID: 36209908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
    Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
    Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer.
    Zuo HX; Jin Y; Wang Z; Li MY; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin CH; Xu GH; Piao LX; Ma J; Jin X
    J Ethnopharmacol; 2020 Jul; 257():112835. PubMed ID: 32278762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data.
    Koh YW; Lee SJ; Han JH; Haam S; Jung J; Lee HW
    Lung Cancer; 2019 Mar; 129():41-47. PubMed ID: 30797490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fraxinellone has anticancer activity in vivo by inhibiting programmed cell death-ligand 1 expression by reducing hypoxia-inducible factor-1α and STAT3.
    Xing Y; Mi C; Wang Z; Zhang ZH; Li MY; Zuo HX; Wang JY; Jin X; Ma J
    Pharmacol Res; 2018 Sep; 135():166-180. PubMed ID: 30103001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N
    Wang Y; Jin P; Wang X
    Apoptosis; 2024 Feb; 29(1-2):142-153. PubMed ID: 37698736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sema3A and HIF1α co-overexpressed iPSC-MSCs/HA scaffold facilitates the repair of calvarial defect in a mouse model.
    Li J; Wang T; Li C; Wang Z; Wang P; Zheng L
    J Cell Physiol; 2020 Oct; 235(10):6754-6766. PubMed ID: 32012286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics.
    Deep G; Kumar R; Nambiar DK; Jain AK; Ramteke AM; Serkova NJ; Agarwal C; Agarwal R
    Mol Carcinog; 2017 Mar; 56(3):833-848. PubMed ID: 27533043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hypoxia-inducible factor 1 inhibitor LW6 mediates the HIF-1α/PD-L1 axis and suppresses tumor growth of hepatocellular carcinoma in vitro and in vivo.
    Xu H; Chen Y; Li Z; Zhang H; Liu J; Han J
    Eur J Pharmacol; 2022 Sep; 930():175154. PubMed ID: 35868447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evodiamine suppresses non-small cell lung cancer by elevating CD8
    Jiang ZB; Huang JM; Xie YJ; Zhang YZ; Chang C; Lai HL; Wang W; Yao XJ; Fan XX; Wu QB; Xie C; Wang MF; Leung EL
    J Exp Clin Cancer Res; 2020 Nov; 39(1):249. PubMed ID: 33208183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-145 transcriptionally regulates Semaphorin 3A expression in prostate cancer cells.
    Barlak N; Capik O; Kilic A; Sanli F; Aytatli A; Yazici A; Karatas EA; Ortucu S; Karatas OF
    Cell Biol Int; 2021 May; 45(5):1082-1090. PubMed ID: 33501702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factor-1α and nuclear factor-κB play important roles in regulating programmed cell death ligand 1 expression by epidermal growth factor receptor mutants in non-small-cell lung cancer cells.
    Guo R; Li Y; Wang Z; Bai H; Duan J; Wang S; Wang L; Wang J
    Cancer Sci; 2019 May; 110(5):1665-1675. PubMed ID: 30844110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semaphorin 3A-hypoxia inducible factor 1 subunit alpha co-overexpression enhances the osteogenic differentiation of induced pluripotent stem cells-derived mesenchymal stem cells in vitro.
    Li JY; Wang TT; Li C; Wang ZF; Li S; Ma L; Zheng LL
    Chin Med J (Engl); 2020 Feb; 133(3):301-309. PubMed ID: 31929360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium Valproate Enhances Semaphorin 3A-mediated Anti-angiogenesis and Tumor Growth Inhibition in Human Osteosarcoma Cells.
    Sawai T; Yamanegi K; Nishiura H; Futani H; Tachibana T
    Anticancer Res; 2023 Jun; 43(6):2539-2550. PubMed ID: 37247909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of evodiamine as a suppressor of prostate cancer progression by reducing AR transcriptional activity via targeting Src.
    Cheng P; Zhang X; Wang X; Liu C; Zhao X; Fan J; Xu C
    Endocrine; 2022 Feb; 75(2):635-645. PubMed ID: 34713388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia promotes the growth and metastasis of ovarian cancer cells by suppressing ferroptosis via upregulating SLC2A12.
    Li M; Li L; Cheng X; Li L; Tu K
    Exp Cell Res; 2023 Dec; 433(2):113851. PubMed ID: 37940066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sema3A drastically suppresses tumor growth in oral cancer Xenograft model of mice.
    Huang C; Wang Y; Huang JH; Liu W
    BMC Pharmacol Toxicol; 2017 Jul; 18(1):55. PubMed ID: 28683823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis.
    Guttmann-Raviv N; Shraga-Heled N; Varshavsky A; Guimaraes-Sternberg C; Kessler O; Neufeld G
    J Biol Chem; 2007 Sep; 282(36):26294-305. PubMed ID: 17569671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eicosapentaenoic acid enhances the sensitivity of osteosarcoma to cisplatin by inducing ferroptosis through the DNA-PKcs/AKT/NRF2 pathway and reducing PD-L1 expression to attenuate immune evasion.
    Zhang Y; Shen G; Meng T; Lv Z; Li X; Li J; Li K
    Int Immunopharmacol; 2023 Dec; 125(Pt B):111181. PubMed ID: 37951196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.